This French Dental Robotics Startup Just Secured Major Funding

Jan de Vries · 2026-08-28

There's a buzz in the air over in Montpellier, France, and it's not just the Mediterranean sun. Lupin Dental, a robotics company that's set its sights on transforming dentistry, just announced the close of its Series A financing round. We're talking about a significant $16.2 million injection of capital. That's a major vote of confidence for a company aiming to bring automation right into the dentist's chair. ### The Funding Breakdown The round was led by Fynveur, which put in a hefty $10.8 million chunk. They weren't alone—existing shareholders and private investors also jumped in. To top it all off, the French public investment bank Bpifrance chipped in with a loan. The interesting part is the strategic partnership. Fynveur, along with its advisor Invus, isn't just writing a check. They're rolling up their sleeves to provide guidance and support. Invus is even taking a seat on the company's board. It's clear the investors are betting on a big vision. Co-founders Dr. Galip Gürel and Dr. Stefen Koubi put it perfectly: “Lupin Dental opens a new chapter with this important milestone. It reflects our investors’ confidence in our vision and enables us to accelerate our mission to transform dental care through innovation.” ### What Lupin Dental Actually Does So, what's all the fuss about? Founded back in 2019, Lupin Dental is laser-focused on one thing: using robots to make complex dental procedures more precise and predictable. Think of it like a super-precise, automated helping hand for dentists. Their flagship product, the Lupin® Robotic System, is designed specifically for preparing teeth for aesthetic veneers. Here's how it works in simple terms: - A software suite first helps design the patient's ideal smile and creates a detailed treatment plan. - Then, the robotic workstation takes over, executing that plan with incredible accuracy to prepare the tooth for the final restoration. The goal is to minimize human error and make these delicate procedures more consistent. It's supervised automation—the dentist is still very much in charge, but the robot handles the ultra-fine, repetitive movements. ### The Road Ahead and Key Hires This fresh capital comes at a pivotal time. The company has already scored some regulatory wins, landing UKCA certification for Great Britain and clearance in India. But here's a crucial note for professionals watching from the United States: the system is **not** currently approved for clinical use in the USA or the European Union. That's the next big hurdle. To help navigate that path and scale the business, Lupin Dental recently brought on some heavy-hitting board members. They appointed Michel Mayer, the former Chairman and CEO of Freescale Semiconductor, as chairman. They also added Philippe Veran, the founder and CEO of Biotech Dental, a major French player in implants and aligners. These aren't just names on a website; they're signals of serious ambition. ### What This Means for the Industry So, where does this funding take them? The plan is all about expansion and adoption. Lupin Dental wants to forge stronger partnerships with academic institutions, medical centers, and dental professionals—from solo practitioners to large Dental Service Organizations (DSOs). The bigger picture here is about a shift in how we think about dental care. It's moving from a purely manual craft to a tech-enhanced practice. For investors and industry watchers in the U.S., it's a compelling case study of European deep-tech innovation targeting a massive, global healthcare market. The success of Lupin Dental could pave the way for more robotics integration in clinics everywhere, changing the patient experience and clinical outcomes. Only time will tell if their bet pays off, but with $16.2 million and a seasoned team, they've certainly got the fuel for the journey.